Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
Article
Chanchlani, Neil, Lin, Simeng, Auth, Marcus K et al. (2022). Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
. 56(8), 1250-1263. 10.1111/apt.17170
Chanchlani, Neil, Lin, Simeng, Auth, Marcus K et al. (2022). Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: Results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study
. 56(8), 1250-1263. 10.1111/apt.17170